Tag: GW Pharmaceuticals plc

GW Pharma to Be Acquired for $220 Per Share

GW Pharmaceuticals plc, Creating an Innovative, High-Growth, Global Biopharma Leader Adds high-growth commercial franchise to Neuroscience portfolio with Epidiolex®, the first and only FDA-approved prescription cannabidiol medicine and a...
- February 3rd, 2021 at 8:08 am

GW Pharma Generates $109 Million Revenue in Q4

GW Pharmaceuticals plc Reports Fourth Quarter and Year-End 2019 Financial Results and Operational Progress Total revenue of $109.1 million for the fourth quarter and $311.3 million for the full...
- February 25th, 2020 at 4:24 pm